Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Non-Small Cell Lung Cancer Clinical Trials
Non-Small Cell Lung Cancer clinical trials are recruiting across 266 cities. Here are the cities with the most active studies:
Non-Small Cell Lung Cancer Trial Phases
55 research organizations are sponsoring non-small cell lung cancer trials.
About Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancers. Subtypes include adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Treatment has been transformed by targeted therapies and immunotherapy based on specific genetic markers.
Clinical trials are advancing new treatments for non-small cell lung cancer. Currently, 100 studies are recruiting a combined 217,045 participants across the United States. Research is being conducted by 55 organizations including University of Utah, SWOG Cancer Research Network, Vanderbilt-Ingram Cancer Center and 52 others.
2026 Non-Small Cell Lung Cancer Research Landscape
As of July 2026, the non-small cell lung cancer clinical trial landscape includes 100 actively recruiting studies across 266 cities in the United States. These studies are collectively seeking 217,045 participants, with an average enrollment target of 2,170 per study.
The research spans multiple phases of development: 47 studies are in PHASE3, 36 studies are in PHASE2, 24 studies are in PHASE1, 5 studies are in NA. The presence of Phase 3 trials indicates that some non-small cell lung cancer treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 55 different organizations, including University of Utah, SWOG Cancer Research Network, Vanderbilt-Ingram Cancer Center, Ohio State University Comprehensive Cancer Center, National Cancer Institute (NCI), and 50 others. The large number of sponsors reflects significant research interest and investment in non-small cell lung cancer treatment advancement.
Geographically, non-small cell lung cancer trials are most concentrated in Los Angeles, California (23 trials); Duarte, California (19 trials); Washington D.C., District of Columbia (16 trials); Boston, Massachusetts (16 trials); Tampa, Florida (15 trials) and 7 other cities.
Featured Non-Small Cell Lung Cancer Studies
Highlighted recruiting studies for non-small cell lung cancer, selected by enrollment size and research scope.
Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data
This research will leverage machine learning (ML) and causal inference techniques applied to real-world data (RWD) to generate evidence that personalizes treatment strategies for patients with advanced non-small cell lung cancer (aNSCLC). Rather than influencing regulatory decisions or clinical guidelines, the goal of this trial is to refine treatment selection among existing therapeutic options, ...
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targete...
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer. PURPOSE: This research study is collecting and analyzing lung tissue samples from patients undergoing surgery for non-small cell lung cancer.
Frequently Asked Questions About Non-Small Cell Lung Cancer Clinical Trials
Are there non-small cell lung cancer clinical trials near me?
Yes, there are 100 non-small cell lung cancer clinical trials currently recruiting across 266+ cities in the United States, including Los Angeles, California; Duarte, California; Washington D.C., District of Columbia. Browse the studies above to find one at a location convenient for you.
How do I join a non-small cell lung cancer clinical trial?
To join a non-small cell lung cancer clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are non-small cell lung cancer clinical trials free?
Yes, participation in non-small cell lung cancer clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of non-small cell lung cancer treatments are being studied?
Current non-small cell lung cancer clinical trials are testing a range of approaches across PHASE3 (47 studies), PHASE2 (36 studies), PHASE1 (24 studies), NA (5 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 55 research organizations.
Is it safe to participate in non-small cell lung cancer clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 17, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 17, 2026 · Data from ClinicalTrials.gov